Your browser is no longer supported. Please, upgrade your browser.
Settings
GH Guardant Health, Inc. daily Stock Chart
GH [NASD]
Guardant Health, Inc.
Index- P/E- EPS (ttm)-2.80 Insider Own0.50% Shs Outstand88.61M Perf Week-14.51%
Market Cap5.80B Forward P/E- EPS next Y-1.15 Insider Trans- Shs Float75.81M Perf Month-14.80%
Income- PEG- EPS next Q-0.37 Inst Own85.30% Short Float3.59% Perf Quarter63.79%
Sales90.70M P/S63.99 EPS this Y7.00% Inst Trans1.74% Short Ratio2.36 Perf Half Y83.01%
Book/sh5.63 P/B11.63 EPS next Y22.80% ROA- Target Price81.75 Perf Year-
Cash/sh4.73 P/C13.86 EPS next 5Y35.70% ROE- 52W Range27.04 - 106.58 Perf YTD74.25%
Dividend- P/FCF- EPS past 5Y- ROI-18.40% 52W High-38.54% Beta-
Dividend %- Quick Ratio9.80 Sales past 5Y- Gross Margin52.40% 52W Low142.23% ATR5.62
Employees454 Current Ratio10.00 Sales Q/Q64.50% Oper. Margin- RSI (14)44.96 Volatility7.85% 7.04%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.64 Prev Close66.72
ShortableYes LT Debt/Eq0.00 EarningsMar 18 AMC Payout- Avg Volume1.15M Price65.50
Recom1.30 SMA20-8.22% SMA50-4.56% SMA20033.57% Volume731,918 Change-1.83%
Apr-16-19Initiated Canaccord Genuity Buy $90
Apr-10-19Upgrade BofA/Merrill Neutral → Buy $81 → $84
Feb-28-19Reiterated BofA/Merrill Neutral $42 → $60
Oct-29-18Initiated William Blair Outperform
Oct-29-18Initiated JP Morgan Overweight $42
Oct-29-18Initiated BofA/Merrill Neutral $37
Apr-24-19 09:15PM  Guardant Health Inc (GH) CEO Helmy Eltoukhy Sold $5.9 million of Shares GuruFocus.com
Apr-23-19 08:38PM  VK Services, LLC Buys Guardant Health Inc GuruFocus.com
03:40PM  What You Must Know About Guardant Health, Inc.'s (NASDAQ:GH) Financial Health Simply Wall St.
08:30AM  Guardant Health Appoints Dr. Bahija Jallal to its Board of Directors GlobeNewswire
Apr-19-19 02:48PM  Top Gene-Sequencing Stocks for 2019 Motley Fool
Apr-15-19 04:37PM  NILE Study Results Demonstrating Guardant360s High Concordance to Tissue Testing in Advanced NSCLC Published in Clinical Cancer Research GlobeNewswire
Apr-10-19 04:41PM  JetBlue and Delta rise while WD-40 slips Associated Press +11.80%
04:32PM  Why First Solar, Guardant Health, and Tempur Sealy International Jumped Today Motley Fool
01:56PM  Bank Of America Upgrades Guardant Health On Huge Growth Potential Benzinga
01:21PM  Why Guardant Health Stock Just Popped 10% Motley Fool
09:55AM  Stocks Rise As Growth Leads: Delta Earnings Top; Hot IPO Offers Buying Opportunity Investor's Business Daily
Apr-09-19 05:24PM  Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360 GlobeNewswire
12:52PM  Here's Why Guardant Health Stock Gained 15.1% in March Motley Fool
Mar-28-19 09:29AM  Palmetto GBA issues Draft Local Coverage Determination Expanding Guardant360 Medicare Coverage to Most Solid Tumor Types GlobeNewswire
Mar-27-19 08:00AM  Guardant Health Announces Definitive Agreement to Acquire Bellwether Bio GlobeNewswire -6.35%
Mar-24-19 11:31AM  3 Stocks That Are Up More Than 100% in 2019 Motley Fool
Mar-21-19 04:20PM  Better Buy: Illumina vs. Guardant Health Motley Fool
Mar-20-19 07:32AM  Jim Cramer Weighs In On Alibaba, Kimberly Clark And More Benzinga
Mar-19-19 07:48PM  Guardant Health Inc (GH) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Mar-16-19 04:30PM  3 More Stocks That Have More Than Doubled in 2019 Motley Fool
Mar-15-19 11:07PM  Guardant Health (GH) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-14-19 04:16PM  This Recent Diagnostics IPO Is Having An Astronomical Run Here's Why Investor's Business Daily
02:42PM  Harry Boxers 4 stocks running on earnings MarketWatch
Mar-13-19 05:17PM  Vera Bradley and Guardant Health surge while Express falls Associated Press +27.64%
04:31PM  Why Oaktree Capital Group, Guardant Health, and Clean Energy Fuels Jumped Today Motley Fool
11:55AM  Guardant Health Posts Healthy Post-Earnings Gains TheStreet.com
11:48AM  Guardant Health Is Growing Like Gangbusters Motley Fool
10:43AM  Why Guardant Health Is Roaring Higher Today Motley Fool
07:12AM  Dow Jones Futures: This Big-Cap Index Is Leading Now; Red-Hot IPO Tops Views Investor's Business Daily
Mar-12-19 06:14PM  Guardant Health: 4Q Earnings Snapshot Associated Press +10.75%
04:05PM  Guardant Health Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Full Year 2019 Outlook GlobeNewswire
07:16AM  Why Guardant Health Is the Best Healthcare Stock You've Never Heard Of Motley Fool
01:58AM  Guardant Health to Present at the 39th Annual Cowen Health Care Conference GlobeNewswire
01:33AM  Guardant Health to Report Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019 GlobeNewswire
Mar-11-19 05:08PM  Here's Why Guardant Health Soared 65.2% in February Motley Fool +6.20%
Mar-04-19 05:00AM  Precision Oncology Gives Guardant Stock Room to Run MoneyShow
Feb-28-19 04:32PM  Why Monster Beverage, Horizon Pharma, and Guardant Health Jumped Today Motley Fool +19.71%
11:57AM  Why Guardant Health Stock Is Jumping Today Motley Fool
Feb-27-19 04:30PM  Guardant360 Performance Matches Standard-of-Care Tissue Testing in First-Line, Advanced Non-Small Cell Lung Cancer, NILE Study Shows, Meeting Primary Endpoint GlobeNewswire
Feb-23-19 06:31AM  3 Top Healthcare Stocks to Buy Right Now Motley Fool
Feb-21-19 05:02PM  Baron Funds' Top 5 Buys in the 4th Quarter GuruFocus.com
Feb-20-19 11:35AM  Hot Cancer Detection Stock Still Has Room to Run TheStreet.com
Feb-14-19 04:05PM  Guardant Health to Present at the 8th Annual Leerink Partners Global Healthcare Conference GlobeNewswire +13.49%
Jan-29-19 09:38AM  What's next for this slow-moving Peninsula biotech IPO? American City Business Journals
Jan-18-19 12:51PM  Do Institutions Own Guardant Health, Inc. (NASDAQ:GH) Shares? Simply Wall St.
Jan-07-19 07:00AM  Guardant Health Announces Launch of the LUNAR Assay for Detection of Early-Stage Cancer and Recurrence to Academic and Biopharmaceutical Researchers GlobeNewswire +5.36%
Dec-24-18 09:53AM  Health Care Digest: 'Killing off' the JPM Week golden goose, a $75 million complement and more American City Business Journals -5.30%
Dec-20-18 07:00PM  Guardant Health to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-13-18 12:15PM  Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi GlobeNewswire
Dec-03-18 03:31PM  The Probable Reason Guardant Health Is Soaring Today Motley Fool +28.58%
Nov-26-18 02:03PM  Here's how much better insiders have profited from this year's IPO boom American City Business Journals
Nov-19-18 04:29PM  Guardant Health reports first earnings since IPO MarketWatch -9.74%
04:05PM  Guardant Health Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-13-18 04:03PM  Guardant Health To Report Third Quarter Financial Results on November 19, 2018 GlobeNewswire
Nov-01-18 02:51PM  Where SoftBanks Vision Fund is deploying its $100 billion Yahoo Finance
Oct-31-18 03:34PM  Strong IPO pace continued in October but some cracks are showing American City Business Journals
Oct-29-18 10:17AM  Health Care Digest: A small biotech goes head first, Gilead's lower tax rate and more American City Business Journals -6.86%
Oct-19-18 08:00AM  Guardant Health Presents Data on Immunotherapy-related Biomarkers MSI and TMB in blood of advanced cancer patients at European Society of Medical Oncology Annual Meeting PR Newswire -10.77%
Oct-16-18 08:00AM  Lung Cancer Study Published in JAMA Oncology Shows Guardant360 Outperforms Tissue Biopsy Alone in Identification of Targetable Mutations PR Newswire +13.04%
Oct-15-18 02:02PM  Unicorn births outpace IPOs in Bay Area: Here are the 24 new ones so far this year American City Business Journals
Oct-09-18 04:03PM  Guardant Health Announces Closing of Initial Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares GlobeNewswire +6.63%
Oct-05-18 08:00AM  Todays Research Reports on Stocks to Watch: Guardant Health and Vaxart ACCESSWIRE -9.32%
Oct-04-18 02:15PM  Nasdaq Welcomes Guardant Health, Inc. (Nasdaq: GH) to The Nasdaq Stock Market GlobeNewswire
11:01AM  Guardant Health IPO: 5 things to know about the startup that wants to detect cancer early MarketWatch
10:55AM  Guardant Health's stock soars in public debut after IPO prices above expectations MarketWatch
09:02AM  Guardant Health IPO prices above expected range to value company at $1.6 billion MarketWatch
Oct-03-18 07:38PM  Guardant Health Announces Pricing of Initial Public Offering GlobeNewswire
Sep-30-18 09:41AM  IPO Outlook For The Week: Diagnostics, Data Miners And Freelance Facilitators Benzinga
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.